Chronic hypoxemia selectively down-regulates 11 beta-hydroxysteroid dehydrogenase type 2 gene expression in the fetal sheep kidney
1998
Murotsuki, J. | Gagnon, R. | Pu, X. | Yang, K.
The present study was designed to examine the effects of chronic fetal placental embolization on the expression of 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD) types 1 and 2, the intracellular enzymes responsible for the metabolism of glucocorticoids. Twelve instrumented fetal sheep were randomly allocated on Day 110 (term = 147 days) to either a control (n = 6) or embolized (n = 6) group. Embolized fetuses received daily injections of nonradioactive microspheres into the abdominal aorta for 21 days to decrease arterial oxygen content by 40-50% of the pre-embolization values. At the end of the experiment, fetal liver and kidney tissues as well as placental cotyledons were collected, and tissue levels of 11 beta-HSD mRNA and activity were determined by standard Northern blot analysis and radiometric conversion assay, respectively. There was a 44% reduction (p < 0.01) in the level of renal 11 beta-HSD2 mRNA in the embolized group as compared with the control group. Moreover, this reduction in mRNA was carried through to 11 beta-HSD2 protein, since there was a corresponding decrease in the level of 11 beta-HSD2 activity (4.5 +/- 0.2 vs. 2.9 +/- 0.1 pmol/min per milligram protein, p < 0.01). In contrast, levels of both 11 beta-HSD1 mRNA and activity in the fetal liver remained unchanged. Moreover, both 11 beta-HSD types 1 and 2 mRNA and activity in the placenta were not altered by the fetal placental embolization. In conclusion, chronic hypoxemia selectively inhibits renal 11 beta-HSD2 mRNA expression and enzyme activity in the ovine fetus, which may contribute, at least in part, to the mechanisms leading to fetal hypertension.
显示更多 [+] 显示较少 [-]